Orygen

Searching for new discoveries

We combine science with the support provided by two of the principle Brazilian pharmaceutical companies to change lives.

We connect knowledge and expertise

We establish partnerships with companies and universities to further the development and application of our product.

We continue to evolve the immunostimulant Hiltonol®

To improve vaccines and other products that require a strong cellular response.

We produce innovative health solutions.

We are Orygen, a research and development biotechnology company focused on immunological products for human and veterinary use.

Learn more about us

We combine the forces of two giants

Eurofarma and Biolab are both shareholders and active participants in the management of Orygen.

Hiltonol^®, a revolutionary immunostimulant

Hiltonol^® is an immunostimulant that functions both as an active vaccine adjuvant and a standalone medication with the potential to have significant impact on both human and veterinary medicine.

Transform tomorrow, be our partner

We believe that the route to discovering new uses for Hiltonol^® lies in collaboration. To that end, we seek to establish new strategic partnerships with academic groups and biotechnology companies in Latin America.